The primary purpose of the acquisition for the Production Assistance for Cellular Therapy (PACT) III program contract awards is to expand the scope of the program by reintroducing the manufacture and distribution of cellular products for use in human subjects participating in clinical trials under investigational new drug (IND) applications for the cell product.
is actively seeking qualified contractors for research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) with a set-aside for WOSB businesses. This set-aside designation means eligible businesses face reduced competition from larger firms.
Looking for more opportunities?
Browse our full directory of government contracts